- Home
- BV vs ARQT Comparison
BV vs ARQT Comparison
Compare BV & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BV
- ARQT
- Stock Information
- Founded
- BV 1939
- ARQT 2016
- Country
- BV United States
- ARQT United States
- Employees
- BV N/A
- ARQT N/A
- Industry
- BV Business Services
- ARQT Biotechnology: Pharmaceutical Preparations
- Sector
- BV Consumer Discretionary
- ARQT Health Care
- Exchange
- BV Nasdaq
- ARQT Nasdaq
- Market Cap
- BV 1.5B
- ARQT 1.7B
- IPO Year
- BV 2018
- ARQT 2020
- Fundamental
- Price
- BV $17.04
- ARQT $13.89
- Analyst Decision
- BV Buy
- ARQT Strong Buy
- Analyst Count
- BV 8
- ARQT 6
- Target Price
- BV $17.41
- ARQT $18.80
- AVG Volume (30 Days)
- BV 832.5K
- ARQT 1.9M
- Earning Date
- BV 07-30-2025
- ARQT 08-13-2025
- Dividend Yield
- BV N/A
- ARQT N/A
- EPS Growth
- BV N/A
- ARQT N/A
- EPS
- BV N/A
- ARQT N/A
- Revenue
- BV $2,729,300,000.00
- ARQT $212,819,000.00
- Revenue This Year
- BV $3.61
- ARQT $61.15
- Revenue Next Year
- BV $2.96
- ARQT $37.98
- P/E Ratio
- BV N/A
- ARQT N/A
- Revenue Growth
- BV N/A
- ARQT 100.03
- 52 Week Low
- BV $11.81
- ARQT $7.86
- 52 Week High
- BV $18.89
- ARQT $17.75
- Technical
- Relative Strength Index (RSI)
- BV 62.96
- ARQT 51.91
- Support Level
- BV $15.79
- ARQT $13.47
- Resistance Level
- BV $16.10
- ARQT $14.69
- Average True Range (ATR)
- BV 0.31
- ARQT 0.63
- MACD
- BV 0.04
- ARQT 0.05
- Stochastic Oscillator
- BV 94.72
- ARQT 68.53
About BV BrightView Holdings Inc.
BrightView Holdings Inc is a provider of commercial landscaping services in the United States. The company provides commercial landscaping services, landscape maintenance, and enhancements to tree care and landscape development. It operates through two segments namely Maintenance Services, and Development Services. The Maintenance Services are self-performed through a national branch network and are route-based in nature. It includes mowing, gardening, mulching and snow removal, water management etc. And Development Services are comprised of sophisticated design, coordination, and installation of landscapes at recognizable corporate, athletic, and university complexes. The company generates a majority of its revenue from Maintenance Services.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.